Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
10 studies found for:    "gene therapy" OR "gene transfer" OR "virus delivery" | Parkinson
Show Display Options
Rank Status Study
1 Terminated Study of AAV-GAD Gene Transfer Into the Subthalamic Nucleus for Parkinson's Disease
Condition: Parkinson's Disease
Intervention: Genetic: Bilateral surgical infusion of AAV-GAD into the subthalamic nucleus
2 Recruiting AADC Gene Therapy for Parkinson's Disease
Condition: Parkinson's Disease
Intervention: Genetic: VY-AADC01
3 Completed Safety Study of Subthalamic Nucleus Gene Therapy for Parkinson's Disease
Condition: Parkinson's Disease
Intervention: Genetic: Surgical infusion of AAV-GAD into the subthalamic nucleus
4 Recruiting AADC Gene Therapy for Parkinson's Disease
Condition: Parkinson Disease
Interventions: Genetic: Cohort1;   Genetic: Cohort2
5 Completed Phase I/II Study of the Safety, Efficacy and Dose Evaluation of ProSavin for the Treatment of Bilateral Idiopathic Parkinson's Disease
Condition: Parkinson's Disease
Intervention: Biological: ProSavin
6 Recruiting AAV2-GDNF for Advanced Parkinson s Disease
Condition: Parkinson's Disease
Intervention: Genetic: Convection enhanced delivery/AAV2-GDNF
7 Terminated Long Term Follow-Up Study for rAAV-GAD Treated Subjects
Condition: Parkinson's Disease
Intervention: Biological: rAAV-GAD
8 Completed Safety of CERE-120 (AAV2-NTN) in Subjects With Idiopathic Parkinson's Disease
Condition: Parkinson's Disease
Intervention: Genetic: CERE-120: AAV2-NTN
9 Active, not recruiting Long Term Safety and Efficacy Study of ProSavin in Parkinson's Disease
Condition: Parkinson's Disease
Intervention: Drug: ProSavin
10 Active, not recruiting Safety and Efficacy of CERE-120 in Subjects With Parkinson's Disease
Condition: Idiopathic Parkinson's Disease
Interventions: Biological: CERE-120: Adeno-Associated Virus Delivery of Neurturin;   Procedure: Sham Surgery

Study has passed its completion date and status has not been verified in more than two years.